-
ACRS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Aclaris Therapeutics (ACRS)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 24.57 mm | 24.57 mm | 24.57 mm | 24.57 mm | 24.57 mm | 24.57 mm |
Cash burn (monthly) | 7.69 mm | 1.28 mm | 33.23 mm | 11.83 mm | 2.98 mm | 1.67 mm |
Cash used (since last report) | 17.60 mm | 2.92 mm | 76.00 mm | 27.05 mm | 6.81 mm | 3.83 mm |
Cash remaining | 6.97 mm | 21.65 mm | -51.43 mm | -2.48 mm | 17.76 mm | 20.74 mm |
Runway (months of cash) | 0.9 | 17.0 | -1.5 | -0.2 | 6.0 | 12.4 |
13F holders | Current |
---|---|
Total holders | 103 |
Opened positions | 37 |
Closed positions | 17 |
Increased positions | 26 |
Reduced positions | 24 |
13F shares | Current |
---|---|
Total value | 212.33 bn |
Total shares | 135.75 mm |
Total puts | 124.00 k |
Total calls | 293.20 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
BML Investment Partners | 14.25 mm | $34.06 mm |
BML Capital Management | 14.25 mm | $35.34 bn |
Biosion | 11.28 mm | $45.02 mm |
Adage Capital Partners GP, L.L.C. | 9.63 mm | $23.88 bn |
Adage Capital Management | 9.63 mm | $23.01 mm |
Vivo Capital | 8.89 mm | $22.04 bn |
Vivo Opportunity Fund | 7.96 mm | $34.37 mm |
Rock Springs Capital Management | 6.20 mm | $15.39 bn |
Ra Capital Management | 4.67 mm | $11.57 bn |
Vanguard | 4.33 mm | $10.73 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 25 | Kevin Balthaser | Common Stock | Payment of exercise | Dispose F | No | No | 1.99 | 727 | 1.45 k | 92,608 |
1 Mar 25 | Kevin Balthaser | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,375 | 0.00 | 93,335 |
1 Mar 25 | Kevin Balthaser | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,100 | 0.00 | 90,960 |
1 Mar 25 | Kevin Balthaser | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,375 | 0.00 | 2,375 |
1 Mar 25 | Kevin Balthaser | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,100 | 0.00 | 0 |
1 Mar 25 | Neal Walker | Common Stock | Payment of exercise | Dispose F | No | No | 1.99 | 3,277 | 6.52 k | 1,466,907 |
1 Mar 25 | Neal Walker | Common Stock | Option exercise | Acquire M | No | No | 0 | 9,466 | 0.00 | 1,470,184 |
1 Mar 25 | Neal Walker | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 9,466 | 0.00 | 18,934 |
1 Mar 25 | Joseph Monahan | Common Stock | Payment of exercise | Dispose F | No | No | 1.99 | 27,258 | 54.24 k | 265,662 |
1 Mar 25 | Joseph Monahan | Common Stock | Option exercise | Acquire M | No | No | 0 | 10,925 | 0.00 | 292,920 |